Siwei Er (斯卫尔)斯卫尔

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

伪麻黄碱是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:伪麻黄碱Weima Huangjian、氯苯那敏Lvben Namin。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:伪麻黄碱-34ee3fb7成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 斯卫尔) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 伪麻黄碱Weima Huangjian, 氯苯那敏Lvben Namin.

Explore other medicines containing the same ingredient: 伪麻黄碱 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 斯卫尔Recorded Chinese name: 斯卫尔
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 盐酸伪麻黄碱60mg,马来酸氯苯那敏4mRecorded Chinese specification: 盐酸伪麻黄碱60mg,马来酸氯苯那敏4m

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 威海诺达药业集团有限公司Chinese legal name: 威海诺达药业集团有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H10980052

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H10980052

Manufacturer

Chinese legal name: 威海诺达药业集团有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H10980052

生产企业

威海诺达药业集团有限公司(国产)

适应症

用于减轻由感冒、枯草热、过敏性鼻炎及鼻窦炎引起的鼻堵塞、流涕、喷嚏等症状。

用法用量

口服,成人每日3次,每次1粒。

不良反应

主要为轻度嗜睡、鼻干、心悸、上腹不适等。

禁忌

对麻黄碱、氯苯那敏过敏者,严重高血压、严重心脏病及前列腺肥大明显者禁用。

注意事项

1.服用量每日不得超过4粒,疗程不超过7天。超量服用可造成头晕、失眠及精神症状。2.心脏病、高血压、甲状腺机能亢进、青光眼、肺气肿等呼吸困难患者及前列腺肥大伴排尿困难患者慎用或不用。3.服药期间不驾驶机动车辆、不操作机器,不从事高空作业。

贮藏

遮光,密闭保存。

规格

盐酸伪麻黄碱60mg,马来酸氯苯那敏4m

证据Evidence

  • 批准文号: 国药准字H10980052
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.